19 November 2024

Howe Street Reporter Title

Tag: Hydroxychloroquine

  • Revive (RVV.C) advances mushroom bio-tech as new regs change the game

    Revive (RVV.C) advances mushroom bio-tech as new regs change the game

    On November 11, 2020 Revive Therapeutics (RVV.C) Revive Therapeutics updated shareholders on its oral thin-film delivery system with psilocybin being developed “under a research partnership agreement with Reed Research Group out of the University of Wisconsin-Madison”. RVV is a specialty life sciences company focused on the R&D of therapeutics for medical needs and rare disorders.…

  • Revive Therapeutics (RVV.C) blasts off, up 68% after FDA Phase 3 COVID-19 approval

    Revive Therapeutics (RVV.C) blasts off, up 68% after FDA Phase 3 COVID-19 approval

    Formerly dismissed-by-many pharmaceutical company Revive Therapeutics (RVV.C) jumped a whopping 68% Friday upon revealing it has been granted approval to move forward with phase 3 clinical trials on the use of its Bucillamine medication as a potential treatment for patients with mild to moderate COVID-19. The U.S. Food and Drug Administration (FDA) has approved Revive…